Skip to main content
Erschienen in: Clinical and Experimental Nephrology 3/2015

01.06.2015 | Original Article

Validation of the Japanese histologic classification 2013 of immunoglobulin A nephropathy for prediction of long-term prognosis in a Japanese single-center cohort

verfasst von: Ryuta Sato, Kensuke Joh, Atsushi Komatsuda, Hiroshi Ohtani, Shin Okuyama, Masaru Togashi, Ayumi Omokawa, Mizuho Nara, Daisuke Nagata, Eiji Kusano, Ken-ichi Sawada, Hideki Wakui

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

A new Japanese histologic classification (JHC) of immunoglobulin A nephropathy (IgAN) for prediction of long-term prognosis was proposed in 2013. The goal of this study was to validate the JHC system in a Japanese single-center cohort.

Methods

A retrospective study was conducted in 198 Japanese adult patients with IgAN. Clinical findings including blood pressure, urinary protein, estimated glomerular filtration rate (eGFR), and outcomes were evaluated in these patients. The glomerular lesion percentage score (GLPS) [number of glomeruli with cellular crescents, fibrocellular crescents, global sclerosis, segmental sclerosis, or fibrous crescents/number of total obtained glomeruli × 100 (%)] was assessed in each patient and categorized into histologic grades (HGs) of HG1 (<25 %), HG2 (25–49 %), and HG3/4 (≥50 %). Associations of GLPS (HG) with disease progression (50 % eGFR decline or end-stage renal disease requiring dialysis) within 10 years after biopsy and the rate of annual eGFR decline were examined.

Results

During a median follow-up period of 12.0 years after biopsy, disease progression occurred in 12.8 % (12/94) of HG1 patients, 32.3 % (21/65) of HG2 patients, and 46.2 % (18/39) of HG3/4 patients. The risk of disease progression was significantly higher in the HG2 and HG3/4 groups than in the HG1 group (odds ratios: 3.3 and 5.9 vs. 1). A higher GLPS was significantly associated with a higher risk of disease progression and a greater annual eGFR decline.

Conclusion

The newly proposed JHC system 2013 based on GLPS (HG) was well correlated with long-term prognosis in our cohort of Japanese adult patients with IgAN.
Literatur
1.
Zurück zum Zitat Berger J, Hinglais N. Les dépots intercapillaires d’IgA–IgG. J Urol Néphrol. 1968;74:694–5 (In French). Berger J, Hinglais N. Les dépots intercapillaires d’IgA–IgG. J Urol Néphrol. 1968;74:694–5 (In French).
2.
Zurück zum Zitat D’Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987;64:709–27.PubMed D’Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987;64:709–27.PubMed
3.
Zurück zum Zitat Nakamoto Y, Asano Y, Dohi K, Fujioka M, Iida H, Kida H, et al. Primary IgA glomerulonephritis and Schönlein-Henoch purpura nephritis: clinicopathological and immunohistological characteristics. Q J Med. 1978;47:495–516.PubMed Nakamoto Y, Asano Y, Dohi K, Fujioka M, Iida H, Kida H, et al. Primary IgA glomerulonephritis and Schönlein-Henoch purpura nephritis: clinicopathological and immunohistological characteristics. Q J Med. 1978;47:495–516.PubMed
4.
Zurück zum Zitat Johnston PA, Brown JS, Braumholtz DA, Davison AK. Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. Q J Med. 1992;84:619–27.PubMed Johnston PA, Brown JS, Braumholtz DA, Davison AK. Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. Q J Med. 1992;84:619–27.PubMed
5.
Zurück zum Zitat Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004;66:920–3.PubMedCrossRef Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004;66:920–3.PubMedCrossRef
6.
Zurück zum Zitat Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, et al. Japan Renal Biopsy Registry and Japan Kidney Disease Registry: committee Report for 2009 and 2010. Clin Exp Nephrol. 2013;17:155–73.PubMedCrossRef Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, et al. Japan Renal Biopsy Registry and Japan Kidney Disease Registry: committee Report for 2009 and 2010. Clin Exp Nephrol. 2013;17:155–73.PubMedCrossRef
8.
Zurück zum Zitat Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Am J Kidney Dis. 1997;29:526–32.PubMedCrossRef Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Am J Kidney Dis. 1997;29:526–32.PubMedCrossRef
9.
Zurück zum Zitat D’Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis. 2000;36:227–37.PubMedCrossRef D’Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis. 2000;36:227–37.PubMedCrossRef
10.
Zurück zum Zitat Cattran DC, Coppo R, Cook HT, Feehally J, Robert ISD, Troyanov S, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76:534–45.PubMedCrossRef Cattran DC, Coppo R, Cook HT, Feehally J, Robert ISD, Troyanov S, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76:534–45.PubMedCrossRef
11.
Zurück zum Zitat Roberts ISD, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76:546–56.PubMedCrossRef Roberts ISD, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76:546–56.PubMedCrossRef
12.
Zurück zum Zitat Kawamura T, Joh K, Okonogi H, Koike K, Utsunomiya Y, Miyazaki Y, Matsushima M, et al. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease. J Nephrol. 2013;26:350–7.PubMedCrossRef Kawamura T, Joh K, Okonogi H, Koike K, Utsunomiya Y, Miyazaki Y, Matsushima M, et al. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease. J Nephrol. 2013;26:350–7.PubMedCrossRef
13.
Zurück zum Zitat Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.PubMedCrossRef Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.PubMedCrossRef
14.
Zurück zum Zitat Levin A, Stevens PE. Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2013;85:49–61.PubMedCrossRef Levin A, Stevens PE. Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2013;85:49–61.PubMedCrossRef
15.
Zurück zum Zitat Lee SMK, Rao VM, Kranklin WA, Schiffer MS, Aronson AJ, Spargo BH, et al. IgA nephropathy: morphological predictors of progressive renal disease. Hum Pathol. 1982;13:314–22.PubMedCrossRef Lee SMK, Rao VM, Kranklin WA, Schiffer MS, Aronson AJ, Spargo BH, et al. IgA nephropathy: morphological predictors of progressive renal disease. Hum Pathol. 1982;13:314–22.PubMedCrossRef
16.
Zurück zum Zitat Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29:829–42.PubMedCrossRef Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29:829–42.PubMedCrossRef
17.
Zurück zum Zitat Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, et al. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee’s glomerular grading system. Nephrol Dial Transplant. 2005;20:342–8.PubMedCrossRef Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, et al. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee’s glomerular grading system. Nephrol Dial Transplant. 2005;20:342–8.PubMedCrossRef
18.
Zurück zum Zitat Katafuchi R, Ninomiya T, Nagata M, Mitsuki K, Hirakata H. Validation study of Oxford classification of IgA nephropathy: the significance of extracapillary proliferation. Clin J Am Soc Nephrol. 2011;6:2806–13.PubMedCentralPubMedCrossRef Katafuchi R, Ninomiya T, Nagata M, Mitsuki K, Hirakata H. Validation study of Oxford classification of IgA nephropathy: the significance of extracapillary proliferation. Clin J Am Soc Nephrol. 2011;6:2806–13.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Tsuchimoto A, Noguchi H, et al. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy. Clin J Am Soc Nephrol. 2013;8:2082–90.PubMedCentralPubMedCrossRef Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Tsuchimoto A, Noguchi H, et al. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy. Clin J Am Soc Nephrol. 2013;8:2082–90.PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, Ponticelli C. Corticosteroids in IgA nephropathy: a randomized controlled trial. Lancet. 1999;353:883–7.PubMedCrossRef Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, Ponticelli C. Corticosteroids in IgA nephropathy: a randomized controlled trial. Lancet. 1999;353:883–7.PubMedCrossRef
21.
Zurück zum Zitat Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15:157–63.PubMedCrossRef Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15:157–63.PubMedCrossRef
22.
Zurück zum Zitat Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001;38:736–43.PubMedCrossRef Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001;38:736–43.PubMedCrossRef
Metadaten
Titel
Validation of the Japanese histologic classification 2013 of immunoglobulin A nephropathy for prediction of long-term prognosis in a Japanese single-center cohort
verfasst von
Ryuta Sato
Kensuke Joh
Atsushi Komatsuda
Hiroshi Ohtani
Shin Okuyama
Masaru Togashi
Ayumi Omokawa
Mizuho Nara
Daisuke Nagata
Eiji Kusano
Ken-ichi Sawada
Hideki Wakui
Publikationsdatum
01.06.2015
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 3/2015
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-014-1004-z

Weitere Artikel der Ausgabe 3/2015

Clinical and Experimental Nephrology 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.